Answers are grounded in this paper and cite their sources.
Comprehensive review examines the effectiveness of transdermal patches in drug delivery, suggesting new applications.
AbstractTransdermal drug delivery systems (TDDS) have revolutionised pharmaceutical therapyby providing a non-invasive route for systemic drug administration through intact skin.This comprehensive review examines the development, evaluation, and clinicalapplications of transdermal patches as an alternative to conventional oral and parenteraldrug delivery. The stratum corneum serves as the primary barrier to drug permeation,necessitating careful selection of drug candidates with appropriate physicochemicalproperties including molecular weight below 500 Da, optimal partition coefficient (log P1-3), and sufficient potency requiring daily doses less than 20 mg. Four major patchdesigns are discussed: drug-in-adhesive systems offering simplified manufacturing,reservoir systems providing precise controlled release, matrix systems ensuring safe drugdelivery without dose-dumping risk, and micro-reservoir systems combining advantagesof both reservoir and matrix technologies. Critical formulation components includingpolymers (natural, synthetic elastomers, and synthetic polymers), permeation enhancers(terpenes, pyrrolidone, surfactants, fatty acids), pressure-sensitive adhesives(polyacrylates, polyisobutylene, silicones), backing layers, and release liners are analysedfor their contributions to optimal patch performance. Various preparation methodsranging from conventional techniques (asymmetric TPX membrane method, circularTeflon mold method, mercury substrate method, hydrogel-based methods) to advancedapproaches (solvent casting, proliposome-based formulations, free film method) andmechanical enhancement technologies (micro-needles, iontophoresis, sonophoresis,electroporation) are comprehensively reviewed. Standardised evaluation parametersencompass physicochemical characterisation (thickness, weight uniformity, drug content,moisture content), mechanical properties (tensile strength, elongation, folding endurance,flatness), adhesion testing (peel adhesion, shear adhesion, tack), and drug release kinetics(in vitro and ex vivo permeation studies). Multiple factors influence transdermal deliveryincluding drug-related parameters (partition coefficient, molecular size, ionisation,solubility, melting point), skin-related variables (age, anatomical site, hydration,temperature, pathological conditions), and formulation factors (vehicle composition,enhancers, occlusion). Clinical applications have been successfully established in painmanagement (fentanyl, buprenorphine, lidocaine patches), smoking cessation (nicotinereplacement therapy), hormonal therapies (oestrogen for menopause, contraceptivepatches), cardiovascular disorders (nitroglycerin, clonidine), and neurological conditions(rivastigmine, rotigotine). Recent technological advances incorporating nanotechnology,
No takes yet. Share an insight, caveat, or question.
Gayathri K, Hariharan V,Vignesh R, Jagadesh S, Pavitharan C, Praveen P, Visvavarma K, Kajnal Mohamed S (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: